1022 
Incidence and Predictors of Anal Squamous Intraepithelial Lesions in the SUN Study after 1 Year of Follow-up
Lois Conley*1, T Bush1, T Darragh2, J Palefsky2, M Kojic3, H Martin4, E Unger1, T Overton5, S Cu-Uvin3, and J Brooks1
1CDC, Atlanta, GA, US; 2Univ of California, San Francisco, US; 3Miriam Hosp, Providence, RI, US; 4Park-Nicollet Inst, Minneapolis, MN, US; and 5Washington Univ Sch of Med, St Louis, MO, US
Background: The incidence of anal cancer and its
precursor squamous intraepithelial lesions (SIL) are increasing in men who have
sex with men (MSM). Incidence of SIL and risk factors for its development in
HIV-infected individuals, including heterosexual men and women, as well as MSM,
have not been extensively investigated.
Methods: The SUN Study is an ongoing prospective
cohort study of HIV-infected outpatients seen at clinics in Denver, Minneapolis, Providence, and St. Louis. At baseline, and annually thereafter, all patients
complete a behavioral risk questionnaire and providers collect, among other
specimens, separate DacronŽ anorectal swabs for cytologic examination as well
as human papilloma virus (HPV) detection and genotyping using the Roche Linear
Assay.
Results: Complete data at both the baseline and
1-year follow-up visits were available for 371 participants. At baseline, 100
patients were diagnosed with anal low-SIL and 28 with high-SIL; these patients
were excluded from this analysis. Of the remaining 243 patients with negative
anal cytology or atypical squamous cells, 76% were male and 86% had HPV
detected. At 1 year, the median age was 42 years, 94% were receiving HAART, 57%
had CD4 cells counts (CD4) ≥500 cells/mm3 (median 529.5
cells/mm3) and 79% had undetectable viral loads. Anal cytologic
results at 1 year were: negative for 190 (78%), atypical squamous cells for 23
(9%), low-SIL for 25 (10%), and high-SIL for 5 (2%). Univariate analysis
indicated that the following factors were associated with incident SIL (p
<0.05): at least 1 high-risk HPV type detected at each visit, a detectable
HIV viral load at each visit, current cigarette smoking, non-adherence (defined
as missing ≥1 ART dose in a 3-day period) and use of >1 illicit drug
(other than marijuana) in the last 30 days. In multivariate analysis, detection
of a high-risk HPV type at each visit (OR 10.4, 95%CI 1.3 to 81, p = 0.026),
detectable viral load at each visit (OR 3.8, 95%CI 1.3 to 11, p = 0.015)
and illicit drug use (OR 6.4, 95%CI 1.0 to 40, p = 0.047) remained
associated.
Conclusions: In this large cohort of generally
healthy, HIV-infected men and women, the incidence of anal SIL at 1 year was
12%. Notably, CD4 level and high-risk sexual behaviors (e.g., unprotected anal
sex, multiple partners) in the previous year were not associated with incident
SIL. Clinicians may wish to consider anal cytology and HPV screening in
HIV-infected patients, particularly if they are found repeatedly to have
detectable HIV viral loads.
|